Parent Project Muscular Dystrophy was joined by Sarepta Therapeutics for a webinar update on June 2, 2021. Sarepta was invited to present recent updates from their ongoing clinical trials, 9001-102 and 9001-103. Research & Clinical Trial Webinars,Webinars 4 years ago You may also like 44:29 Is Myostatin Still a Potential Therapeutic Target? (October 2018) 6 years ago Research & Clinical Trial Webinars,Webinars 1:00:51 Puberty and Duchenne (September 2018) 6 years ago Care Webinars,Webinars 1:09:04 HOPE-2 Duchenne Clinical Trial – Capricor (July 2018) 7 years ago Research & Clinical Trial Webinars,Webinars 1:01:35 Introducing PPMO – Sarepta Therapeutics (May 2018) 7 years ago Research & Clinical Trial Webinars,Webinars 50:18 Roche/Genentech Anti-Myostatin Adnectin RG6206 in Duchenne (May 2018) 7 years ago Research & Clinical Trial Webinars,Webinars 49:43 NS Pharma’s Exon 53 Skipping Program Update (April 2018) 7 years ago Research & Clinical Trial Webinars,Webinars 1:01:32 Gene Therapy: A Closer Look (March 2018) 7 years ago Research & Clinical Trial Webinars,Webinars gene therapy 1:02:50 Pulmonary Care in Adults with Duchenne (March 2018) 7 years ago Care Webinars,Webinars «1…1516171819…26»Page 17 of 26